ESR1 and breast carcinoma: Notwithstanding, Tu et al. [123] established that induced expression of ENO1 by 4-hydroxy-tamoxifen (4-OHT) confers 4-OHT drug-induced resistance in MC7 breast cancer cells via induction of the ER/NFkB pathway [123].